Medical Affairs and Commercial Content
Module 6 · Communication and Accountability

Medical Affairs and Commercial Content

Use AI for scientific communication, medical information, and promotional content while respecting the line between scientific exchange and promotion, fair balance, and medical-legal-regulatory review.

Words That Are Regulated

In most industries, marketing copy is judged by whether it works. In life sciences, what you say about a product is regulated. Claims must be consistent with the approved label, supported by evidence, and balanced with risk information. Medical affairs operates under different rules from promotion, and the line between them matters.

The line AI must not blurScientific exchangeMedical affairsPromotionCommercial• Answers unsolicited questions• Consistent with the approved label• Non-promotional and balanced• Fair balance of benefit and risk• Off-label only when truly asked• Claims backed by adequate evidence• Built from approved content• MLR review before any use

AI is very good at producing persuasive, polished text. That’s exactly why it needs careful handling here.


Medical Affairs Uses

Medical information and standard response letters

Medical information teams answer unsolicited questions from healthcare professionals and patients. AI can help:

  • Find relevant approved content and prior responses.
  • Draft a response from an approved standard response letter, tailored to the specific question.
  • Summarize new literature for updating response letters.

Guardrails: responses must come from approved content, stay non-promotional, and go through your review process. Off-label information can be provided only in response to genuinely unsolicited requests, within your company’s policies. An AI that “helpfully” volunteers off-label uses turns a compliant response into a problem.

Scientific communication

Publication planning, congress materials, medical-science-liaison (MSL) slide decks, and advisory board summaries. The literature and authorship rules from Lesson 3.1 apply, along with good publication practice (such as GPP guidelines) and your company’s publication SOPs.

Insights

MSLs collect field insights from conversations with experts. AI can cluster and summarize large volumes of insight notes. Be careful with what goes into those notes: no identifiable patient information, and no recording of individuals’ views beyond what your policies permit.


Promotional Content

AI can draft promotional copy, adapt materials across channels, and personalize messaging. Every one of those outputs is still promotional material and goes through medical, legal, and regulatory (MLR) review.

AI introduces specific risks:

  • Overstatement. “Significantly reduces” when the trial showed a numerical but non-significant trend. “Proven” when evidence is preliminary.
  • Missing fair balance. Benefit claims without proportionate risk information, or risk information pushed out of sight.
  • Off-label drift. Copy that implies a broader population, indication, or dose than the label supports.
  • Unsupported comparisons. Superiority claims against a competitor without head-to-head evidence.
  • Invented references. Claims annotated with citations that don’t support them, or don’t exist.
⚠️ Common Pitfall: Assuming MLR Will Catch Everything

Common mistake: generating many AI variants of promotional content and relying on MLR review to catch problems.

MLR reviewers are a control, not a filter for unlimited volume. More AI-generated variants means more review burden and more chances for an error to get through. Constrain AI to approved claims and references at the start, so what reaches MLR is already close to compliant.


A Claims-Anchored Workflow

  1. 1 Claims library

    Approved claims and references

  2. 2 Constrained draft

    AI uses only the library

  3. 3 Self-check

    Claim-by-claim vs. library

  4. 4 Fair balance

    Risk info prominent

  5. 5 MLR review

    Full standard review

  6. 6 Archive

    Approved version and use

Claim not in the approved library → remove it, or route it to medical for substantiation

The key move is the claims library: a set of pre-approved claims, each linked to its supporting reference and approved wording. When AI may only assemble and adapt approved claims, rather than inventing new ones, both quality and review speed improve.


Personalization and Patient-Facing Content

AI-driven personalization of messages to healthcare professionals and patients raises extra questions:

  • Is the personalization based on data you’re allowed to use for this purpose?
  • Does every version still carry required risk information?
  • Is each variant reviewed, or is the template plus the rules for variation approved?
  • For patient-facing content, is it at an appropriate reading level, and does it avoid making medical decisions for the patient?
🧪 Try It: Audit an AI Draft Against the Label

Using a public product label (prescribing information) and an approved tool:

  1. Ask the AI to write a short, persuasive paragraph for healthcare professionals about the product.
  2. Check every claim against the label. Mark each as on-label, overstated, or not supported.
  3. Check whether risk information is present and proportionate.

Then rewrite the prompt to constrain the AI to label language, and compare.

🧠 Knowledge Check

1. A medical information response drafted by AI volunteers an off-label use the requester didn't ask about. What's the issue?

2. What does a claims library do in an AI-assisted promotional workflow?

3. AI copy says a drug "significantly reduces" symptoms, but the trial showed a non-significant numerical trend. What kind of error is this?

Up Next

The final lesson brings everything together into personal and team accountability, and a 90-day plan.